Login / Signup

Osthole Antagonizes Microglial Activation in an NRF2-Dependent Manner.

Chuan-Hsiu LiuMei-Ying ChenYueh-Hsiung KuoJack ChengLi-Zhong ChangMeng-Shiun ChangTsai-Ni ChuangWen-Tsong HsiehYan-Ru XiaoBor-Tsang WuWei-Yong LinHsin-Ping Liu
Published in: Molecules (Basel, Switzerland) (2023)
Microglia are neuroglia in the brain with an innate immune function and participate in the progress of neurodegenerative diseases. Osthole (OST) is a coumarin derivative extracted from Cnidium monnieri and bears a microglia-antagonizing ability. However, the underlying mechanism of the antagonism is not clear. The lipopolysaccharides-induced microglial BV2 cell line and amyloid-overexpressing fruit fly were used as models to study OST treatment. We found that OST treatment is sufficient to evoke NRF2 cascade under an LPS-induced inflammatory environment, and silencing NRF2 is sufficient to abolish the process. Moreover, we found that OST is sufficient to antagonize microglial activation in both LPS-induced BV2 cells and Aβ-overexpressing fruit flies, and silencing NRF2 abolishes OST's antagonism. Furthermore, OST treatment rescued survival, climbing, and the learning ability of Aβ-overexpressing fruit flies and relieved oxidative stress. In conclusion, we proved that OST antagonizes microglial activation induced by either LPS or Aβ and that NRF2 is necessary for OST's antagonism.
Keyphrases